tiprankstipranks
Trending News
More News >

Atrys Health Reports Strong Financial Growth in 2024

Story Highlights
Atrys Health Reports Strong Financial Growth in 2024

Confident Investing Starts Here:

An announcement from Atrys Health SA ( (ES:ATRY) ) is now available.

Atrys Health SA reported a revenue increase of 5.5% in 2024, reaching 212.7 million euros, with a significant EBITDA growth of 13.8% to 48.5 million euros. The company reduced its negative consolidated result by 31% and improved its leverage ratio, reflecting the strength and efficiency of its business model. Atrys experienced growth across all business areas, particularly in oncology, driven by its activities in Mexico, and saw notable revenue increases in Spain, Portugal, and Latin America.

More about Atrys Health SA

Atrys is a global healthtech company specializing in prevention, diagnosis, and precision medical treatment services. It is a leader in telemedicine and oncology treatment, with operations in seven countries across Europe and Latin America, and is the only listed company in the health technology sector in Spain.

YTD Price Performance: -10.40%

Average Trading Volume: 245

Technical Sentiment Signal: Strong Buy

Current Market Cap: €234.8M

See more data about ATRY stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App